NICE rejects first-line use of Roche’s Gazyvaro

18th September 2017 Uncategorised 0

The National Institute for Health and Care Excellence has turned down first-line use of Roche’s Gazyvaro in patients with untreated advanced follicular lymphoma on the NHS in England and Wales.

More: NICE rejects first-line use of Roche’s Gazyvaro
Source: News